Dexrazoxane Hydrochloride Patent Expiration
Dexrazoxane Hydrochloride is Used for managing extravasation caused by IV anthracycline chemotherapy. It was first introduced by Pfizer Inc
Dexrazoxane Hydrochloride Patents
Given below is the list of patents protecting Dexrazoxane Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Totect | US6727253 | Treatment of accidental extravasation of anthracyclines |
Mar 13, 2020
(Expired) | Clinigen |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Dexrazoxane Hydrochloride's patents.
Latest Legal Activities on Dexrazoxane Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Dexrazoxane Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail-Petition Decision - Dismissed Critical
| 05 Oct, 2016 | US6727253 |
| Petition Decision - Dismissed Critical
| 05 Oct, 2016 | US6727253 |
| Petition Entered | 04 Apr, 2016 | US6727253 |
| Change in Power of Attorney (May Include Associate POA) Critical
| 17 Sep, 2013 | US6727253 |
| Correspondence Address Change Critical
| 16 Sep, 2013 | US6727253 |
| Recordation of Patent Grant Mailed Critical
| 27 Apr, 2004 | US6727253 |
| Patent Issue Date Used in PTA Calculation Critical
| 27 Apr, 2004 | US6727253 |
| Issue Notification Mailed Critical
| 08 Apr, 2004 | US6727253 |
| Receipt into Pubs | 18 Mar, 2004 | US6727253 |
| Application Is Considered Ready for Issue Critical
| 17 Mar, 2004 | US6727253 |
Dexrazoxane Hydrochloride's Family Patents
